Mushroom supplement shows promise for fatty liver in new trial

NCT ID NCT07534241

Recruiting now Disease control Sponsor: University of Lahore Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This 12-week study tests whether reishi mushroom supplements can improve liver health in 102 adults with metabolic fatty liver disease. Participants will take reishi mushroom powder or a placebo, alongside a probiotic-rich diet. Researchers will measure changes in liver enzymes, cholesterol, and inflammation to see if the supplement offers any benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: reishi mushroom (Ganoderma lucidum) dried powder
What this could lead to: If it works, this could point toward a natural supplement to help manage fatty liver disease and reduce the need for medications.
What could go wrong: This is a small, early-stage trial with only 102 people. The supplement may not work better than placebo, and results may not apply to everyone with fatty liver disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPID PROFILE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIPID PROFILE LIVER BIOMARKERS

Contacts and locations

Locations

Sana Noreen
RECRUITING

Lahore, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.